Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Citi
Cipla
AstraZeneca
Merck
Deloitte
Medtronic
McKinsey
Baxter

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,028,222

« Back to Dashboard

Which drugs does patent 6,028,222 protect, and when does it expire?

Patent 6,028,222 protects OFIRMEV and is included in one NDA.

Protection for OFIRMEV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has twenty-nine patent family members in twenty-one countries.
Summary for Patent: 6,028,222
Title: Stable liquid paracetamol compositions, and method for preparing same
Abstract:Novel stable paracetamol compositions for use in therapeutic chemistry and specifically galenic pharmacy are disclosed. The compositions contain a solution of paracetamol in an aqueous solvent combined with a buffer having a pH of 4 to 8, and a free radical capturing agent. A water-insoluble inert gas is carefully bubbled through the aqueous solvent to remove oxygen from the medium. Said compositions may also be combined with a centrally or peripherally acting analgesic agent, and are provided as injectable compositions for relieving pain.
Inventor(s): Dietlin; Francois (Le Pecq, FR), Fredj; Daniele (Gif-sur-Yvette, FR)
Assignee: SCR Pharmatop (FR)
Application Number:09/051,246
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,028,222
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;

Drugs Protected by US Patent 6,028,222

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mallinckrodt Ip OFIRMEV acetaminophen SOLUTION;IV (INFUSION) 022450-001 Nov 2, 2010 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,028,222

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France96 09858Aug 05, 1996
France96 09858Aug 5, 1996
PCT Information
PCT FiledAugust 05, 1997PCT Application Number:PCT/FR97/01452
PCT Publication Date:February 12, 1998PCT Publication Number: WO98/05314

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Deloitte
Chubb
Dow
Cipla
Fish and Richardson
Julphar
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.